Birdwatch Note
2023-07-26 02:59:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
国際的にも手術、抗がん剤治療(化学療法)、放射線治療は、がんに対する標準治療です。 https://www.cancer.gov/about-cancer/treatment/types/surgery https://www.cancer.gov/about-cancer/treatment/types/chemotherapy https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy がん治療に伴う死亡はゼロではありませんが、たとえば進行した肺がん患者であっても1~2%という報告があります。80%ががんの三大療法で死んでいるという信頼できる報告はありません。 https://pubmed.ncbi.nlm.nih.gov/12094134/
Written by 5E4EEEAEFEC4653B759CA2693ACBC3AA1FFE1CD4BAE4AA88B66211844AF3FAD4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1683623489109123073
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1684035766085906434
- noteId - 1684035766085906434
- participantId -
- noteAuthorParticipantId - 5E4EEEAEFEC4653B759CA2693ACBC3AA1FFE1CD4BAE4AA88B66211844AF3FAD4 Participant Details
- createdAtMillis - 1690340389164
- tweetId - 1683623489109123073
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 国際的にも手術、抗がん剤治療(化学療法)、放射線治療は、がんに対する標準治療です。 https://www.cancer.gov/about-cancer/treatment/types/surgery https://www.cancer.gov/about-cancer/treatment/types/chemotherapy https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy がん治療に伴う死亡はゼロではありませんが、たとえば進行した肺がん患者であっても1~2%という報告があります。80%ががんの三大療法で死んでいるという信頼できる報告はありません。 https://pubmed.ncbi.nlm.nih.gov/12094134/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-07-26 02:59:49 UTC (1690340389164) |
2023-07-26 11:09:43 UTC (1690369783874) |
CURRENTLY_RATED_HELPFUL | 2023-07-27 02:13:23 UTC (1690424003614) |
CURRENTLY_RATED_HELPFUL | 2023-07-26 11:09:43 UTC (1690369783874) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-07-26 14:37:29 -0500 | Rating Details | |
2023-07-26 12:14:43 -0500 | Rating Details | |
2023-07-26 10:51:31 -0500 | Rating Details | |
2023-07-26 10:44:11 -0500 | Rating Details | |
2023-07-26 07:11:09 -0500 | Rating Details | |
2023-07-26 06:35:58 -0500 | Rating Details | |
2023-07-26 06:26:09 -0500 | Rating Details | |
2023-07-26 06:24:37 -0500 | Rating Details | |
2023-07-26 06:15:09 -0500 | Rating Details | |
2023-07-26 06:11:49 -0500 | Rating Details | |
2023-07-26 06:04:46 -0500 | Rating Details | |
2023-07-26 06:04:14 -0500 | Rating Details | |
2023-07-26 05:56:52 -0500 | Rating Details | |
2023-07-26 05:56:06 -0500 | Rating Details | |
2023-07-26 05:46:15 -0500 | Rating Details | |
2023-07-26 05:42:30 -0500 | Rating Details | |
2023-07-26 05:37:57 -0500 | Rating Details | |
2023-07-26 05:35:44 -0500 | Rating Details | |
2023-07-26 05:34:28 -0500 | Rating Details | |
2023-07-26 05:21:16 -0500 | Rating Details | |
2023-07-26 04:56:39 -0500 | Rating Details | |
2023-07-26 04:42:07 -0500 | Rating Details | |
2023-07-26 04:22:02 -0500 | Rating Details | |
2023-07-26 04:20:26 -0500 | Rating Details | |
2023-07-26 04:18:36 -0500 | Rating Details | |
2023-07-26 04:18:35 -0500 | Rating Details | |
2023-07-26 04:11:32 -0500 | Rating Details | |
2023-07-26 04:11:18 -0500 | Rating Details | |
2023-07-26 04:09:00 -0500 | Rating Details | |
2023-07-26 04:07:28 -0500 | Rating Details | |
2023-07-26 04:01:22 -0500 | Rating Details | |
2023-07-26 03:50:48 -0500 | Rating Details | |
2023-07-26 03:44:36 -0500 | Rating Details | |
2023-07-26 03:41:35 -0500 | Rating Details | |
2023-07-26 03:37:02 -0500 | Rating Details | |
2023-07-26 03:35:46 -0500 | Rating Details | |
2023-07-26 03:23:34 -0500 | Rating Details | |
2023-07-26 03:22:00 -0500 | Rating Details | |
2023-07-26 03:18:40 -0500 | Rating Details | |
2023-07-26 03:05:16 -0500 | Rating Details | |
2023-07-26 02:23:56 -0500 | Rating Details | |
2023-07-26 01:23:34 -0500 | Rating Details | |
2023-07-26 01:21:24 -0500 | Rating Details | |
2023-07-26 00:35:20 -0500 | Rating Details | |
2023-07-26 00:33:45 -0500 | Rating Details | |
2023-07-26 00:10:26 -0500 | Rating Details | |
2023-07-25 23:23:46 -0500 | Rating Details | |
2023-07-25 23:08:13 -0500 | Rating Details | |
2023-07-25 22:59:08 -0500 | Rating Details | |
2023-07-25 22:58:04 -0500 | Rating Details | |
2023-07-25 22:54:07 -0500 | Rating Details | |
2023-07-25 22:22:38 -0500 | Rating Details | |
2023-07-25 22:10:45 -0500 | Rating Details | |
2023-07-25 22:05:45 -0500 | Rating Details | |
2023-07-27 05:05:12 -0500 | Rating Details | |
2023-07-27 04:06:39 -0500 | Rating Details | |
2023-07-27 02:23:28 -0500 | Rating Details | |
2023-07-27 00:58:46 -0500 | Rating Details | |
2023-07-26 23:51:43 -0500 | Rating Details | |
2023-07-26 23:04:18 -0500 | Rating Details | |
2023-07-26 22:48:33 -0500 | Rating Details | |
2023-07-26 21:50:49 -0500 | Rating Details | |
2023-07-26 20:55:10 -0500 | Rating Details | |
2023-07-28 12:10:37 -0500 | Rating Details | |
2023-07-28 01:53:25 -0500 | Rating Details | |
2023-07-27 08:12:57 -0500 | Rating Details | |
2023-07-26 16:58:14 -0500 | Rating Details | |
2023-07-30 16:09:21 -0500 | Rating Details | |
2023-07-31 18:13:38 -0500 | Rating Details | |
2023-07-31 17:56:30 -0500 | Rating Details | |
2023-07-31 09:45:51 -0500 | Rating Details | |
2023-07-31 08:08:27 -0500 | Rating Details | |
2023-07-31 07:43:06 -0500 | Rating Details | |
2023-08-01 18:42:59 -0500 | Rating Details | |
2023-08-01 17:11:50 -0500 | Rating Details | |
2023-08-01 16:43:07 -0500 | Rating Details | |
2023-08-01 12:07:49 -0500 | Rating Details | |
2023-08-01 06:59:57 -0500 | Rating Details | |
2023-08-01 06:08:41 -0500 | Rating Details | |
2023-08-01 06:02:19 -0500 | Rating Details | |
2023-08-01 05:37:09 -0500 | Rating Details | |
2023-08-01 05:16:58 -0500 | Rating Details | |
2023-08-01 03:40:27 -0500 | Rating Details | |
2023-08-01 03:31:15 -0500 | Rating Details | |
2023-08-01 03:24:54 -0500 | Rating Details | |
2023-08-01 03:21:04 -0500 | Rating Details | |
2023-08-01 03:20:22 -0500 | Rating Details | |
2023-08-01 03:00:21 -0500 | Rating Details | |
2023-08-01 02:51:49 -0500 | Rating Details | |
2023-08-01 02:15:10 -0500 | Rating Details | |
2023-08-01 02:09:54 -0500 | Rating Details | |
2023-08-01 02:08:22 -0500 | Rating Details | |
2023-08-01 01:36:20 -0500 | Rating Details | |
2023-08-01 01:14:26 -0500 | Rating Details | |
2023-08-01 00:26:50 -0500 | Rating Details | |
2023-07-31 23:51:23 -0500 | Rating Details | |
2023-07-31 21:38:59 -0500 | Rating Details | |
2023-07-31 19:49:53 -0500 | Rating Details | |
2023-07-31 19:34:05 -0500 | Rating Details | |
2023-08-02 07:58:08 -0500 | Rating Details | |
2023-08-02 06:06:06 -0500 | Rating Details | |
2023-08-02 02:54:52 -0500 | Rating Details | |
2023-08-02 02:36:19 -0500 | Rating Details | |
2023-08-02 01:41:03 -0500 | Rating Details | |
2023-08-01 22:36:21 -0500 | Rating Details | |
2023-08-01 22:24:29 -0500 | Rating Details | |
2023-08-01 21:13:33 -0500 | Rating Details | |
2023-08-01 21:02:12 -0500 | Rating Details | |
2023-08-01 19:48:43 -0500 | Rating Details | |
2023-08-01 09:54:55 -0500 | Rating Details | |
2023-08-01 00:07:03 -0500 | Rating Details | |
2023-08-03 00:58:37 -0500 | Rating Details | |
2023-08-01 06:16:52 -0500 | Rating Details | |
2023-07-25 22:34:44 -0500 | Rating Details | |
2023-08-04 10:09:07 -0500 | Rating Details | |
2023-08-04 05:41:33 -0500 | Rating Details | |
2023-08-01 05:53:40 -0500 | Rating Details | |
2023-08-01 17:12:18 -0500 | Rating Details | |
2023-08-05 21:32:20 -0500 | Rating Details | |
2023-08-09 10:19:38 -0500 | Rating Details | |
2023-08-11 05:09:51 -0500 | Rating Details | |
2023-08-21 03:56:12 -0500 | Rating Details |